Global Gene-based Therapy Medicinal Market Growth (Status and Outlook) 2026-2032
The global Gene-based Therapy Medicinal market size is predicted to grow from US$ 17260 million in 2025 to US$ 89230 million in 2032; it is expected to grow at a CAGR of 27.0% from 2026 to 2032.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.
LPI (LP Information)' newest research report, the “Gene-based Therapy Medicinal Industry Forecast” looks at past sales and reviews total world Gene-based Therapy Medicinal sales in 2025, providing a comprehensive analysis by region and market sector of projected Gene-based Therapy Medicinal sales for 2026 through 2032. With Gene-based Therapy Medicinal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene-based Therapy Medicinal industry.
This Insight Report provides a comprehensive analysis of the global Gene-based Therapy Medicinal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene-based Therapy Medicinal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene-based Therapy Medicinal market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene-based Therapy Medicinal and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene-based Therapy Medicinal.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene-based Therapy Medicinal market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.
LPI (LP Information)' newest research report, the “Gene-based Therapy Medicinal Industry Forecast” looks at past sales and reviews total world Gene-based Therapy Medicinal sales in 2025, providing a comprehensive analysis by region and market sector of projected Gene-based Therapy Medicinal sales for 2026 through 2032. With Gene-based Therapy Medicinal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene-based Therapy Medicinal industry.
This Insight Report provides a comprehensive analysis of the global Gene-based Therapy Medicinal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene-based Therapy Medicinal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene-based Therapy Medicinal market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene-based Therapy Medicinal and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene-based Therapy Medicinal.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene-based Therapy Medicinal market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Viral Gene Delivery System
- Non-viral Gene Delivery System
- Neurological Diseases
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene-based Therapy Medicinal Market Size (2021-2032)
2.1.2 Gene-based Therapy Medicinal Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Gene-based Therapy Medicinal by Country/Region (2021, 2025 & 2032)
2.2 Gene-based Therapy Medicinal Segment by Type
2.2.1 Viral Gene Delivery System
2.2.2 Non-viral Gene Delivery System
2.2.3 Gene-based Therapy Medicinal Market Size by Type
2.2.3.1 Gene-based Therapy Medicinal Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
2.3 Gene-based Therapy Medicinal Segment by Application
2.3.1 Neurological Diseases
2.3.2 Cancer
2.3.3 Other
2.3.4 Gene-based Therapy Medicinal Market Size by Application
2.3.4.1 Gene-based Therapy Medicinal Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
3 GENE-BASED THERAPY MEDICINAL MARKET SIZE BY PLAYER
3.1 Gene-based Therapy Medicinal Market Size Market Share by Player
3.1.1 Global Gene-based Therapy Medicinal Revenue by Player (2021-2026)
3.1.2 Global Gene-based Therapy Medicinal Revenue Market Share by Player (2021-2026)
3.2 Global Gene-based Therapy Medicinal Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE-BASED THERAPY MEDICINAL BY REGION
4.1 Gene-based Therapy Medicinal Market Size by Region (2021-2026)
4.2 Global Gene-based Therapy Medicinal Annual Revenue by Country/Region (2021-2026)
4.3 Americas Gene-based Therapy Medicinal Market Size Growth (2021-2026)
4.4 APAC Gene-based Therapy Medicinal Market Size Growth (2021-2026)
4.5 Europe Gene-based Therapy Medicinal Market Size Growth (2021-2026)
4.6 Middle East & Africa Gene-based Therapy Medicinal Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Gene-based Therapy Medicinal Market Size by Country (2021-2026)
5.2 Americas Gene-based Therapy Medicinal Market Size by Type (2021-2026)
5.3 Americas Gene-based Therapy Medicinal Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene-based Therapy Medicinal Market Size by Region (2021-2026)
6.2 APAC Gene-based Therapy Medicinal Market Size by Type (2021-2026)
6.3 APAC Gene-based Therapy Medicinal Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene-based Therapy Medicinal Market Size by Country (2021-2026)
7.2 Europe Gene-based Therapy Medicinal Market Size by Type (2021-2026)
7.3 Europe Gene-based Therapy Medicinal Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene-based Therapy Medicinal by Region (2021-2026)
8.2 Middle East & Africa Gene-based Therapy Medicinal Market Size by Type (2021-2026)
8.3 Middle East & Africa Gene-based Therapy Medicinal Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE-BASED THERAPY MEDICINAL MARKET FORECAST
10.1 Global Gene-based Therapy Medicinal Forecast by Region (2027-2032)
10.1.1 Global Gene-based Therapy Medicinal Forecast by Region (2027-2032)
10.1.2 Americas Gene-based Therapy Medicinal Forecast
10.1.3 APAC Gene-based Therapy Medicinal Forecast
10.1.4 Europe Gene-based Therapy Medicinal Forecast
10.1.5 Middle East & Africa Gene-based Therapy Medicinal Forecast
10.2 Americas Gene-based Therapy Medicinal Forecast by Country (2027-2032)
10.2.1 United States Market Gene-based Therapy Medicinal Forecast
10.2.2 Canada Market Gene-based Therapy Medicinal Forecast
10.2.3 Mexico Market Gene-based Therapy Medicinal Forecast
10.2.4 Brazil Market Gene-based Therapy Medicinal Forecast
10.3 APAC Gene-based Therapy Medicinal Forecast by Region (2027-2032)
10.3.1 China Gene-based Therapy Medicinal Market Forecast
10.3.2 Japan Market Gene-based Therapy Medicinal Forecast
10.3.3 Korea Market Gene-based Therapy Medicinal Forecast
10.3.4 Southeast Asia Market Gene-based Therapy Medicinal Forecast
10.3.5 India Market Gene-based Therapy Medicinal Forecast
10.3.6 Australia Market Gene-based Therapy Medicinal Forecast
10.4 Europe Gene-based Therapy Medicinal Forecast by Country (2027-2032)
10.4.1 Germany Market Gene-based Therapy Medicinal Forecast
10.4.2 France Market Gene-based Therapy Medicinal Forecast
10.4.3 UK Market Gene-based Therapy Medicinal Forecast
10.4.4 Italy Market Gene-based Therapy Medicinal Forecast
10.4.5 Russia Market Gene-based Therapy Medicinal Forecast
10.5 Middle East & Africa Gene-based Therapy Medicinal Forecast by Region (2027-2032)
10.5.1 Egypt Market Gene-based Therapy Medicinal Forecast
10.5.2 South Africa Market Gene-based Therapy Medicinal Forecast
10.5.3 Israel Market Gene-based Therapy Medicinal Forecast
10.5.4 Turkey Market Gene-based Therapy Medicinal Forecast
10.6 Global Gene-based Therapy Medicinal Forecast by Type (2027-2032)
10.7 Global Gene-based Therapy Medicinal Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Gene-based Therapy Medicinal Forecast
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene-based Therapy Medicinal Product Offered
11.1.3 Biogen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene-based Therapy Medicinal Product Offered
11.2.3 Novartis Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene-based Therapy Medicinal Product Offered
11.3.3 Gilead Sciences Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene-based Therapy Medicinal Product Offered
11.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Offered
11.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene-based Therapy Medicinal Product Offered
11.6.3 Amgen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene-based Therapy Medicinal Product Offered
11.7.3 Spark Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene-based Therapy Medicinal Product Offered
11.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Information
11.9.2 Sunway Biotech Gene-based Therapy Medicinal Product Offered
11.9.3 Sunway Biotech Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sunway Biotech Main Business Overview
11.9.5 Sunway Biotech Latest Developments
11.10 SIBIONO
11.10.1 SIBIONO Company Information
11.10.2 SIBIONO Gene-based Therapy Medicinal Product Offered
11.10.3 SIBIONO Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 SIBIONO Main Business Overview
11.10.5 SIBIONO Latest Developments
11.11 AnGes
11.11.1 AnGes Company Information
11.11.2 AnGes Gene-based Therapy Medicinal Product Offered
11.11.3 AnGes Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AnGes Main Business Overview
11.11.5 AnGes Latest Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Information
11.12.2 Orchard Therapeutics Gene-based Therapy Medicinal Product Offered
11.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Orchard Therapeutics Main Business Overview
11.12.5 Orchard Therapeutics Latest Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Information
11.13.2 Human Stem Cells Institute Gene-based Therapy Medicinal Product Offered
11.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Human Stem Cells Institute Main Business Overview
11.13.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene-based Therapy Medicinal Market Size (2021-2032)
2.1.2 Gene-based Therapy Medicinal Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Gene-based Therapy Medicinal by Country/Region (2021, 2025 & 2032)
2.2 Gene-based Therapy Medicinal Segment by Type
2.2.1 Viral Gene Delivery System
2.2.2 Non-viral Gene Delivery System
2.2.3 Gene-based Therapy Medicinal Market Size by Type
2.2.3.1 Gene-based Therapy Medicinal Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
2.3 Gene-based Therapy Medicinal Segment by Application
2.3.1 Neurological Diseases
2.3.2 Cancer
2.3.3 Other
2.3.4 Gene-based Therapy Medicinal Market Size by Application
2.3.4.1 Gene-based Therapy Medicinal Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
3 GENE-BASED THERAPY MEDICINAL MARKET SIZE BY PLAYER
3.1 Gene-based Therapy Medicinal Market Size Market Share by Player
3.1.1 Global Gene-based Therapy Medicinal Revenue by Player (2021-2026)
3.1.2 Global Gene-based Therapy Medicinal Revenue Market Share by Player (2021-2026)
3.2 Global Gene-based Therapy Medicinal Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE-BASED THERAPY MEDICINAL BY REGION
4.1 Gene-based Therapy Medicinal Market Size by Region (2021-2026)
4.2 Global Gene-based Therapy Medicinal Annual Revenue by Country/Region (2021-2026)
4.3 Americas Gene-based Therapy Medicinal Market Size Growth (2021-2026)
4.4 APAC Gene-based Therapy Medicinal Market Size Growth (2021-2026)
4.5 Europe Gene-based Therapy Medicinal Market Size Growth (2021-2026)
4.6 Middle East & Africa Gene-based Therapy Medicinal Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Gene-based Therapy Medicinal Market Size by Country (2021-2026)
5.2 Americas Gene-based Therapy Medicinal Market Size by Type (2021-2026)
5.3 Americas Gene-based Therapy Medicinal Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene-based Therapy Medicinal Market Size by Region (2021-2026)
6.2 APAC Gene-based Therapy Medicinal Market Size by Type (2021-2026)
6.3 APAC Gene-based Therapy Medicinal Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene-based Therapy Medicinal Market Size by Country (2021-2026)
7.2 Europe Gene-based Therapy Medicinal Market Size by Type (2021-2026)
7.3 Europe Gene-based Therapy Medicinal Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene-based Therapy Medicinal by Region (2021-2026)
8.2 Middle East & Africa Gene-based Therapy Medicinal Market Size by Type (2021-2026)
8.3 Middle East & Africa Gene-based Therapy Medicinal Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE-BASED THERAPY MEDICINAL MARKET FORECAST
10.1 Global Gene-based Therapy Medicinal Forecast by Region (2027-2032)
10.1.1 Global Gene-based Therapy Medicinal Forecast by Region (2027-2032)
10.1.2 Americas Gene-based Therapy Medicinal Forecast
10.1.3 APAC Gene-based Therapy Medicinal Forecast
10.1.4 Europe Gene-based Therapy Medicinal Forecast
10.1.5 Middle East & Africa Gene-based Therapy Medicinal Forecast
10.2 Americas Gene-based Therapy Medicinal Forecast by Country (2027-2032)
10.2.1 United States Market Gene-based Therapy Medicinal Forecast
10.2.2 Canada Market Gene-based Therapy Medicinal Forecast
10.2.3 Mexico Market Gene-based Therapy Medicinal Forecast
10.2.4 Brazil Market Gene-based Therapy Medicinal Forecast
10.3 APAC Gene-based Therapy Medicinal Forecast by Region (2027-2032)
10.3.1 China Gene-based Therapy Medicinal Market Forecast
10.3.2 Japan Market Gene-based Therapy Medicinal Forecast
10.3.3 Korea Market Gene-based Therapy Medicinal Forecast
10.3.4 Southeast Asia Market Gene-based Therapy Medicinal Forecast
10.3.5 India Market Gene-based Therapy Medicinal Forecast
10.3.6 Australia Market Gene-based Therapy Medicinal Forecast
10.4 Europe Gene-based Therapy Medicinal Forecast by Country (2027-2032)
10.4.1 Germany Market Gene-based Therapy Medicinal Forecast
10.4.2 France Market Gene-based Therapy Medicinal Forecast
10.4.3 UK Market Gene-based Therapy Medicinal Forecast
10.4.4 Italy Market Gene-based Therapy Medicinal Forecast
10.4.5 Russia Market Gene-based Therapy Medicinal Forecast
10.5 Middle East & Africa Gene-based Therapy Medicinal Forecast by Region (2027-2032)
10.5.1 Egypt Market Gene-based Therapy Medicinal Forecast
10.5.2 South Africa Market Gene-based Therapy Medicinal Forecast
10.5.3 Israel Market Gene-based Therapy Medicinal Forecast
10.5.4 Turkey Market Gene-based Therapy Medicinal Forecast
10.6 Global Gene-based Therapy Medicinal Forecast by Type (2027-2032)
10.7 Global Gene-based Therapy Medicinal Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Gene-based Therapy Medicinal Forecast
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene-based Therapy Medicinal Product Offered
11.1.3 Biogen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene-based Therapy Medicinal Product Offered
11.2.3 Novartis Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene-based Therapy Medicinal Product Offered
11.3.3 Gilead Sciences Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene-based Therapy Medicinal Product Offered
11.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Offered
11.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene-based Therapy Medicinal Product Offered
11.6.3 Amgen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene-based Therapy Medicinal Product Offered
11.7.3 Spark Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene-based Therapy Medicinal Product Offered
11.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Information
11.9.2 Sunway Biotech Gene-based Therapy Medicinal Product Offered
11.9.3 Sunway Biotech Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sunway Biotech Main Business Overview
11.9.5 Sunway Biotech Latest Developments
11.10 SIBIONO
11.10.1 SIBIONO Company Information
11.10.2 SIBIONO Gene-based Therapy Medicinal Product Offered
11.10.3 SIBIONO Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 SIBIONO Main Business Overview
11.10.5 SIBIONO Latest Developments
11.11 AnGes
11.11.1 AnGes Company Information
11.11.2 AnGes Gene-based Therapy Medicinal Product Offered
11.11.3 AnGes Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AnGes Main Business Overview
11.11.5 AnGes Latest Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Information
11.12.2 Orchard Therapeutics Gene-based Therapy Medicinal Product Offered
11.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Orchard Therapeutics Main Business Overview
11.12.5 Orchard Therapeutics Latest Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Information
11.13.2 Human Stem Cells Institute Gene-based Therapy Medicinal Product Offered
11.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Human Stem Cells Institute Main Business Overview
11.13.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene-based Therapy Medicinal Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Gene-based Therapy Medicinal Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Viral Gene Delivery System
Table 4. Major Players of Non-viral Gene Delivery System
Table 5. Gene-based Therapy Medicinal Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Gene-based Therapy Medicinal Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
Table 8. Gene-based Therapy Medicinal Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Gene-based Therapy Medicinal Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
Table 11. Global Gene-based Therapy Medicinal Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Gene-based Therapy Medicinal Revenue Market Share by Player (2021-2026)
Table 13. Gene-based Therapy Medicinal Key Players Head office and Products Offered
Table 14. Gene-based Therapy Medicinal Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene-based Therapy Medicinal Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Gene-based Therapy Medicinal Market Size Market Share by Region (2021-2026)
Table 19. Global Gene-based Therapy Medicinal Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Gene-based Therapy Medicinal Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Gene-based Therapy Medicinal Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Gene-based Therapy Medicinal Market Size Market Share by Country (2021-2026)
Table 23. Americas Gene-based Therapy Medicinal Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
Table 25. Americas Gene-based Therapy Medicinal Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
Table 27. APAC Gene-based Therapy Medicinal Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Gene-based Therapy Medicinal Market Size Market Share by Region (2021-2026)
Table 29. APAC Gene-based Therapy Medicinal Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Gene-based Therapy Medicinal Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Gene-based Therapy Medicinal Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Gene-based Therapy Medicinal Market Size Market Share by Country (2021-2026)
Table 33. Europe Gene-based Therapy Medicinal Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Gene-based Therapy Medicinal Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Gene-based Therapy Medicinal Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Gene-based Therapy Medicinal Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Gene-based Therapy Medicinal Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene-based Therapy Medicinal
Table 39. Key Market Challenges & Risks of Gene-based Therapy Medicinal
Table 40. Key Industry Trends of Gene-based Therapy Medicinal
Table 41. Global Gene-based Therapy Medicinal Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Gene-based Therapy Medicinal Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Gene-based Therapy Medicinal Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Biogen Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 46. Biogen Gene-based Therapy Medicinal Product Offered
Table 47. Biogen Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Biogen Main Business
Table 49. Biogen Latest Developments
Table 50. Novartis Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 51. Novartis Gene-based Therapy Medicinal Product Offered
Table 52. Novartis Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Gilead Sciences Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 56. Gilead Sciences Gene-based Therapy Medicinal Product Offered
Table 57. Gilead Sciences Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences Latest Developments
Table 60. Sarepta Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 61. Sarepta Therapeutics Gene-based Therapy Medicinal Product Offered
Table 62. Sarepta Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Sarepta Therapeutics Main Business
Table 64. Sarepta Therapeutics Latest Developments
Table 65. Alnylam Pharmaceuticals Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 66. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Offered
Table 67. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Alnylam Pharmaceuticals Main Business
Table 69. Alnylam Pharmaceuticals Latest Developments
Table 70. Amgen Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 71. Amgen Gene-based Therapy Medicinal Product Offered
Table 72. Amgen Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Amgen Main Business
Table 74. Amgen Latest Developments
Table 75. Spark Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 76. Spark Therapeutics Gene-based Therapy Medicinal Product Offered
Table 77. Spark Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Spark Therapeutics Main Business
Table 79. Spark Therapeutics Latest Developments
Table 80. Akcea Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 81. Akcea Therapeutics Gene-based Therapy Medicinal Product Offered
Table 82. Akcea Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Akcea Therapeutics Main Business
Table 84. Akcea Therapeutics Latest Developments
Table 85. Sunway Biotech Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 86. Sunway Biotech Gene-based Therapy Medicinal Product Offered
Table 87. Sunway Biotech Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Sunway Biotech Main Business
Table 89. Sunway Biotech Latest Developments
Table 90. SIBIONO Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 91. SIBIONO Gene-based Therapy Medicinal Product Offered
Table 92. SIBIONO Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. SIBIONO Main Business
Table 94. SIBIONO Latest Developments
Table 95. AnGes Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 96. AnGes Gene-based Therapy Medicinal Product Offered
Table 97. AnGes Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. AnGes Main Business
Table 99. AnGes Latest Developments
Table 100. Orchard Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 101. Orchard Therapeutics Gene-based Therapy Medicinal Product Offered
Table 102. Orchard Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Orchard Therapeutics Main Business
Table 104. Orchard Therapeutics Latest Developments
Table 105. Human Stem Cells Institute Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 106. Human Stem Cells Institute Gene-based Therapy Medicinal Product Offered
Table 107. Human Stem Cells Institute Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Human Stem Cells Institute Main Business
Table 109. Human Stem Cells Institute Latest Developments
Table 1. Gene-based Therapy Medicinal Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Gene-based Therapy Medicinal Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Viral Gene Delivery System
Table 4. Major Players of Non-viral Gene Delivery System
Table 5. Gene-based Therapy Medicinal Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Gene-based Therapy Medicinal Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
Table 8. Gene-based Therapy Medicinal Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Gene-based Therapy Medicinal Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
Table 11. Global Gene-based Therapy Medicinal Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Gene-based Therapy Medicinal Revenue Market Share by Player (2021-2026)
Table 13. Gene-based Therapy Medicinal Key Players Head office and Products Offered
Table 14. Gene-based Therapy Medicinal Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene-based Therapy Medicinal Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Gene-based Therapy Medicinal Market Size Market Share by Region (2021-2026)
Table 19. Global Gene-based Therapy Medicinal Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Gene-based Therapy Medicinal Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Gene-based Therapy Medicinal Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Gene-based Therapy Medicinal Market Size Market Share by Country (2021-2026)
Table 23. Americas Gene-based Therapy Medicinal Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
Table 25. Americas Gene-based Therapy Medicinal Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
Table 27. APAC Gene-based Therapy Medicinal Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Gene-based Therapy Medicinal Market Size Market Share by Region (2021-2026)
Table 29. APAC Gene-based Therapy Medicinal Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Gene-based Therapy Medicinal Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Gene-based Therapy Medicinal Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Gene-based Therapy Medicinal Market Size Market Share by Country (2021-2026)
Table 33. Europe Gene-based Therapy Medicinal Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Gene-based Therapy Medicinal Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Gene-based Therapy Medicinal Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Gene-based Therapy Medicinal Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Gene-based Therapy Medicinal Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene-based Therapy Medicinal
Table 39. Key Market Challenges & Risks of Gene-based Therapy Medicinal
Table 40. Key Industry Trends of Gene-based Therapy Medicinal
Table 41. Global Gene-based Therapy Medicinal Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Gene-based Therapy Medicinal Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Gene-based Therapy Medicinal Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Biogen Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 46. Biogen Gene-based Therapy Medicinal Product Offered
Table 47. Biogen Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Biogen Main Business
Table 49. Biogen Latest Developments
Table 50. Novartis Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 51. Novartis Gene-based Therapy Medicinal Product Offered
Table 52. Novartis Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Gilead Sciences Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 56. Gilead Sciences Gene-based Therapy Medicinal Product Offered
Table 57. Gilead Sciences Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences Latest Developments
Table 60. Sarepta Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 61. Sarepta Therapeutics Gene-based Therapy Medicinal Product Offered
Table 62. Sarepta Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Sarepta Therapeutics Main Business
Table 64. Sarepta Therapeutics Latest Developments
Table 65. Alnylam Pharmaceuticals Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 66. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Offered
Table 67. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Alnylam Pharmaceuticals Main Business
Table 69. Alnylam Pharmaceuticals Latest Developments
Table 70. Amgen Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 71. Amgen Gene-based Therapy Medicinal Product Offered
Table 72. Amgen Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Amgen Main Business
Table 74. Amgen Latest Developments
Table 75. Spark Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 76. Spark Therapeutics Gene-based Therapy Medicinal Product Offered
Table 77. Spark Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Spark Therapeutics Main Business
Table 79. Spark Therapeutics Latest Developments
Table 80. Akcea Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 81. Akcea Therapeutics Gene-based Therapy Medicinal Product Offered
Table 82. Akcea Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Akcea Therapeutics Main Business
Table 84. Akcea Therapeutics Latest Developments
Table 85. Sunway Biotech Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 86. Sunway Biotech Gene-based Therapy Medicinal Product Offered
Table 87. Sunway Biotech Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Sunway Biotech Main Business
Table 89. Sunway Biotech Latest Developments
Table 90. SIBIONO Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 91. SIBIONO Gene-based Therapy Medicinal Product Offered
Table 92. SIBIONO Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. SIBIONO Main Business
Table 94. SIBIONO Latest Developments
Table 95. AnGes Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 96. AnGes Gene-based Therapy Medicinal Product Offered
Table 97. AnGes Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. AnGes Main Business
Table 99. AnGes Latest Developments
Table 100. Orchard Therapeutics Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 101. Orchard Therapeutics Gene-based Therapy Medicinal Product Offered
Table 102. Orchard Therapeutics Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Orchard Therapeutics Main Business
Table 104. Orchard Therapeutics Latest Developments
Table 105. Human Stem Cells Institute Details, Company Type, Gene-based Therapy Medicinal Area Served and Its Competitors
Table 106. Human Stem Cells Institute Gene-based Therapy Medicinal Product Offered
Table 107. Human Stem Cells Institute Gene-based Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Human Stem Cells Institute Main Business
Table 109. Human Stem Cells Institute Latest Developments
LIST OF FIGURES
Figure 1. Gene-based Therapy Medicinal Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene-based Therapy Medicinal Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Gene-based Therapy Medicinal Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Gene-based Therapy Medicinal Sales Market Share by Country/Region (2025)
Figure 8. Gene-based Therapy Medicinal Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Gene-based Therapy Medicinal Market Size Market Share by Type in 2025
Figure 10. Gene-based Therapy Medicinal in Neurological Diseases
Figure 11. Global Gene-based Therapy Medicinal Market: Neurological Diseases (2021-2026) & ($ millions)
Figure 12. Gene-based Therapy Medicinal in Cancer
Figure 13. Global Gene-based Therapy Medicinal Market: Cancer (2021-2026) & ($ millions)
Figure 14. Gene-based Therapy Medicinal in Other
Figure 15. Global Gene-based Therapy Medicinal Market: Other (2021-2026) & ($ millions)
Figure 16. Global Gene-based Therapy Medicinal Market Size Market Share by Application in 2025
Figure 17. Global Gene-based Therapy Medicinal Revenue Market Share by Player in 2025
Figure 18. Global Gene-based Therapy Medicinal Market Size Market Share by Region (2021-2026)
Figure 19. Americas Gene-based Therapy Medicinal Market Size 2021-2026 ($ millions)
Figure 20. APAC Gene-based Therapy Medicinal Market Size 2021-2026 ($ millions)
Figure 21. Europe Gene-based Therapy Medicinal Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Gene-based Therapy Medicinal Market Size 2021-2026 ($ millions)
Figure 23. Americas Gene-based Therapy Medicinal Value Market Share by Country in 2025
Figure 24. United States Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Gene-based Therapy Medicinal Market Size Market Share by Region in 2025
Figure 29. APAC Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
Figure 30. APAC Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
Figure 31. China Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 35. India Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Gene-based Therapy Medicinal Market Size Market Share by Country in 2025
Figure 38. Europe Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
Figure 39. Europe Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
Figure 40. Germany Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 41. France Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 54. APAC Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 55. Europe Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 57. United States Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 58. Canada Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 59. Mexico Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 60. Brazil Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 61. China Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 62. Japan Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 63. Korea Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 65. India Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 66. Australia Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 67. Germany Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 68. France Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 69. UK Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 70. Italy Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 71. Russia Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 72. Egypt Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 73. South Africa Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 74. Israel Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 75. Turkey Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 76. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 1. Gene-based Therapy Medicinal Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene-based Therapy Medicinal Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Gene-based Therapy Medicinal Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Gene-based Therapy Medicinal Sales Market Share by Country/Region (2025)
Figure 8. Gene-based Therapy Medicinal Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Gene-based Therapy Medicinal Market Size Market Share by Type in 2025
Figure 10. Gene-based Therapy Medicinal in Neurological Diseases
Figure 11. Global Gene-based Therapy Medicinal Market: Neurological Diseases (2021-2026) & ($ millions)
Figure 12. Gene-based Therapy Medicinal in Cancer
Figure 13. Global Gene-based Therapy Medicinal Market: Cancer (2021-2026) & ($ millions)
Figure 14. Gene-based Therapy Medicinal in Other
Figure 15. Global Gene-based Therapy Medicinal Market: Other (2021-2026) & ($ millions)
Figure 16. Global Gene-based Therapy Medicinal Market Size Market Share by Application in 2025
Figure 17. Global Gene-based Therapy Medicinal Revenue Market Share by Player in 2025
Figure 18. Global Gene-based Therapy Medicinal Market Size Market Share by Region (2021-2026)
Figure 19. Americas Gene-based Therapy Medicinal Market Size 2021-2026 ($ millions)
Figure 20. APAC Gene-based Therapy Medicinal Market Size 2021-2026 ($ millions)
Figure 21. Europe Gene-based Therapy Medicinal Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Gene-based Therapy Medicinal Market Size 2021-2026 ($ millions)
Figure 23. Americas Gene-based Therapy Medicinal Value Market Share by Country in 2025
Figure 24. United States Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Gene-based Therapy Medicinal Market Size Market Share by Region in 2025
Figure 29. APAC Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
Figure 30. APAC Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
Figure 31. China Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 35. India Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Gene-based Therapy Medicinal Market Size Market Share by Country in 2025
Figure 38. Europe Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
Figure 39. Europe Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
Figure 40. Germany Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 41. France Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Gene-based Therapy Medicinal Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Gene-based Therapy Medicinal Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 54. APAC Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 55. Europe Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 57. United States Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 58. Canada Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 59. Mexico Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 60. Brazil Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 61. China Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 62. Japan Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 63. Korea Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 65. India Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 66. Australia Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 67. Germany Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 68. France Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 69. UK Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 70. Italy Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 71. Russia Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 72. Egypt Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 73. South Africa Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 74. Israel Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 75. Turkey Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
Figure 76. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Gene-based Therapy Medicinal Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Gene-based Therapy Medicinal Market Size 2027-2032 ($ millions)
